A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
Pant, S., Saleh, M., Bendell, J., Infante, J.R., Jones, S., Kurkjian, C.D., Moore, K.M., Kazakin, J., Abbadessa, G., Wang, Y., Chen, Y., Schwartz, B., Camacho, L.H.
Published in Annals of oncology (01.07.2014)
Published in Annals of oncology (01.07.2014)
Get full text
Journal Article
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
Burris, Howard A., Kurkjian, C. D., Hart, L., Pant, S., Murphy, P. B., Jones, S. F., Neuwirth, R., Patel, C. G., Zohren, F., Infante, J. R.
Published in Cancer chemotherapy and pharmacology (01.08.2017)
Published in Cancer chemotherapy and pharmacology (01.08.2017)
Get full text
Journal Article
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
Pant, S, Saleh, M, Bendell, J, Infante, J R, Jones, S, Kurkjian, C D, Moore, K M, Kazakin, J, Abbadessa, G, Wang, Y, Chen, Y, Schwartz, B, Camacho, L H
Published in Annals of oncology (01.07.2014)
Get full text
Published in Annals of oncology (01.07.2014)
Journal Article
DNA Methylation: Its Role in Cancer Development and Therapy
Kurkjian, C., MD, Kummar, S., MD, Murgo, A.J., MD, MS
Published in Current problems in cancer (01.09.2008)
Published in Current problems in cancer (01.09.2008)
Get full text
Journal Article